Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J M Bos

Showing results (11-20 of 24) with videos related to

Pageof 3
Sort By:
Vaccine|May 4, 2004
Pharmaco-economic evaluation of targeted hepatitis A vaccination for children of ethnic minorities in Amsterdam (The Netherlands)M J Postma, J M Bos, Ph Beutels, et al.
Pharmacoeconomics|January 6, 2000
Economic evaluation of influenza vaccination. Assessment for The NetherlandsM J Postma, J M Bos, M van Gennep, et al.
The Journal of Biological Chemistry|August 30, 1996
Enhanced thrombin sensitivity of a factor VIII-heparin cofactor II hybridJ Voorberg, G van Stempvoort, J M Bos, et al.
Bulletin of the World Health Organization|January 1, 1976
Large-scale use of freeze-dried smallpox vaccine prepared in primary cultures of rabbit kidney cellsA C Hekker, J M Bos, N K Rai, et al.
European Journal of Hospital Pharmacy : Science and Practice|June 4, 2019
QTc prolongation during erythromycin used as prokinetic agent in ICU patientsR B Fiets, J M Bos, Art Donders, et al.
European Journal of Applied Physiology|September 18, 2007
Distribution of motor unit potential velocities in short static and prolonged dynamic contractions at low forces: use of the within-subject's skewness and standard deviation variablesE G Klaver-Król, N R Henriquez, S J Oosterloo, et al.
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|September 29, 2004
Do costs of varicella justify routine infant vaccination? Pharmacoeconomic and clinical considerationsM J Postma, J M Bos, R Welte, et al.
Vaccine|March 16, 2007
Enhanced decision support for policy makers using a web interface to health-economic models--illustrated with a cost-effectiveness analysis of nation-wide infant vaccination with the 7-valent pneumococcal conjugate vaccine in the NetherlandsG A A Hubben, J M Bos, D M Glynn, et al.
Journal of the American Medical Informatics Association : JAMIA|December 10, 1997
A voice-enabled, structured medical reporting systemD F Rosenthal, J M Bos, R A Sokolowski, et al.
Vaccine|August 21, 2007
The use of health economics to guide drug development decisions: Determining optimal values for an RSV-vaccine in a model-based scenario-analytic approachJ M Bos, E Rietveld, H A Moll, et al.
Pageof 3

Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
Vaccine|May 4, 2004
Pharmaco-economic evaluation of targeted hepatitis A vaccination for children of ethnic minorities in Amsterdam (The Netherlands)M J Postma, J M Bos, Ph Beutels, et al.
Pharmacoeconomics|January 6, 2000
Economic evaluation of influenza vaccination. Assessment for The NetherlandsM J Postma, J M Bos, M van Gennep, et al.
The Journal of Biological Chemistry|August 30, 1996
Enhanced thrombin sensitivity of a factor VIII-heparin cofactor II hybridJ Voorberg, G van Stempvoort, J M Bos, et al.
Bulletin of the World Health Organization|January 1, 1976
Large-scale use of freeze-dried smallpox vaccine prepared in primary cultures of rabbit kidney cellsA C Hekker, J M Bos, N K Rai, et al.
European Journal of Hospital Pharmacy : Science and Practice|June 4, 2019
QTc prolongation during erythromycin used as prokinetic agent in ICU patientsR B Fiets, J M Bos, Art Donders, et al.
European Journal of Applied Physiology|September 18, 2007
Distribution of motor unit potential velocities in short static and prolonged dynamic contractions at low forces: use of the within-subject's skewness and standard deviation variablesE G Klaver-Król, N R Henriquez, S J Oosterloo, et al.
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|September 29, 2004
Do costs of varicella justify routine infant vaccination? Pharmacoeconomic and clinical considerationsM J Postma, J M Bos, R Welte, et al.
Vaccine|March 16, 2007
Enhanced decision support for policy makers using a web interface to health-economic models--illustrated with a cost-effectiveness analysis of nation-wide infant vaccination with the 7-valent pneumococcal conjugate vaccine in the NetherlandsG A A Hubben, J M Bos, D M Glynn, et al.
Journal of the American Medical Informatics Association : JAMIA|December 10, 1997
A voice-enabled, structured medical reporting systemD F Rosenthal, J M Bos, R A Sokolowski, et al.
Vaccine|August 21, 2007
The use of health economics to guide drug development decisions: Determining optimal values for an RSV-vaccine in a model-based scenario-analytic approachJ M Bos, E Rietveld, H A Moll, et al.
Pageof 3